Joint Collaboration Committee. The parties agree to continue their active support and commitment to the Joint Collaboration Committee (JCC). Utilizing the collaboration process, the Committee will continue to meet regularly to address issues and interests brought by the parties. The Committee will be composed of a minimum of eight members, four appointed by the Association and four appointed by the superintendent, including the chief operating officer. The Committee will be co-chaired by the chief operating officer and the presi- dent of the Association. The JCC will provide for regular, on-going discussions and decision-making on matters germane to union-management relations and, when appropriate, to the continuous improvement of instruction and school system operations. The parties are committed to ensuring that this is an effective, collabo- rative process to address interests and concerns and resolve problems. The overall charge to the JCC shall include but not be limited to the following: • Interpreting and administering the implementation of the negotiated Agreement • Discussing any matters of interest or concern • Reaching tentative agreements on issues in a timely manner • Providing oversight and final decision-making authority for the A&S PGS • Reviewing and assessing the effectiveness of collaboration between MCPS and MCAAP/MCBOA • Reviewing annually the guidelines for the professional learning communities. When appropriate, the JCC will make written recommendations to the superintendent and the Board of Directors of the Association on issues brought forward for consideration on which they have reached a consensus for resolution that supports continuous improvement within the school system. The JCC will have the following authorities: • To establish temporary committees and work groups to address specific issues. Such groups will report back to the JCC. The JCC shall be authorized to consolidate, reconfigure the membership of, modify the charge and tasks of, and discontinue joint committees or work groups. In addition the JCC will interpret and review implementation plans for decisions made by these collaborative decision-making groups. • To clarify language and meaning, correct contradictions or inconsistencies, and remove outdated language. • To resolve problems arising out of the interpretation or implementation of collaborative agreements and decisions. • To encourage individuals to utilize the Alternative Dispute Resolution process when they have differences or problems t...
Joint Collaboration Committee. (a) The Parties will establish a joint steering committee (the “Joint Collaboration Committee” or “JCC”) to oversee the Parties’ activities under this Agreement. Within [*], Portola shall appoint two (2) representatives to the JCC, and each of BMS and Pfizer shall appoint one (1) representative to the JCC and notify the other Parties of the dates of availability for the first meeting of the JCC. The JCC may change its size from time to time by mutual consent of its members and each Party may replace its representatives at any time upon written notice to the other Parties. Each Party’s JCC representatives shall include an officer or employee of such Party with sufficient seniority to make decisions arising within the JCC’s responsibilities.
Joint Collaboration Committee. The Parties may, by mutual agreement at any time, establish a joint collaboration committee (the “JCC”) to provide a forum for the Parties to exchange information with respect to the exercise of their rights and performance of their obligations in accordance with this Agreement. The responsibilities of the JCC shall be decided by the Parties if and when such JCC is formed, and may include:
Joint Collaboration Committee. (JCC) for Labor-Management Cooperative Initiatives The parties will establish a joint committee to confer on labor management initiatives the parties undertake. These joint initiatives are intended to enhance and develop employees as the Company's key resource and improve productivity and efficiency. The JCC’s responsibilities may include: (1) establishing subcommittees to confer on the initiatives; (2) reviewing, expanding initiatives where appropriate and resolving issues related to ongoing initiatives; and
Joint Collaboration Committee. For purposes of describing the general scope of the collaboration only, and subject to the obligations set forth more specifically in other sections of this Agreement, the Parties contemplate that Zosano would be responsible for management and funding of further Development activities and regulatory activities necessary to support registration of the Licensed Products in accordance with the Development Plan and, in the event Zosano achieves the Critical Success Factors, Lilly shall make the applicable milestone payments and thereafter be solely responsible for the conduct and funding of all Commercialization activities. Accordingly, the purpose of the JCC is to facilitate periodic communication between the Parties regarding their activities under this Agreement. The JCC will not serve as an alliance decision making body, nor will it have the power to amend or waive compliance with, or the terms of, this Agreement or determine whether a Party has committed a breach of this Agreement. For the avoidance of doubt, the JCC shall have no authority to determine whether a Development milestone should be pursued or amended or is achieved.
Joint Collaboration Committee. The overall charge to the JCC shall include but not be limited to the following: ● Interpreting and administering the implementation of the negotiated Agreement ● Discussing any matters of interest or concern ● Reaching tentative agreements on issues in a timely manner ● Providing oversight and final decision-making authority for the A&S PGS ● Reviewing and assessing the effectiveness of collaboration between MCPS and MCAAP/XXXXX ● Reviewing annually the guidelines for the professional learning communities ● Review compliance with the memorandum distribution process at least annually. *** To review feedback for the revised principal handbook.
Joint Collaboration Committee. (JCC) for Labor-Management Cooperative Initiatives The parties will establish a joint committee to confer on labor management initiatives the parties undertake. These joint initiatives are intended to enhance and develop employees as the Company's key resource and improve productivity and efficiency. The JCC’s responsibilities may include: (1) establishing subcommittees to confer on the initiatives; (2) reviewing, expanding initiatives where appropriate and resolving issues related to ongoing initiatives; and (3) formulating future labor-management cooperative initiatives. The Company at its sole discretion will provide administrative staff and appropriate funding to support the initiatives. To create a proper environment for the committee's work, no aspect of the committee's proceedings shall be used as the basis for, or as evidence in, any proceedings under Article 3.
Joint Collaboration Committee. ALLIANCE MANAGER 16 5.1 Joint Collaboration Committee 16 5.2 Alliance Managers 18 ARTICLE 6 INTELLECTUAL PROPERTY 18 6.1 Ownership of Inventions 18 ARTICLE 7 REPRESENTATIONS AND WARRANTIES 19 7.1 Representations and Warranties 19 7.2 No Other Warranties 20 ARTICLE 8 INDEMNIFICATION 20 8.1 Indemnification by the Company 20 8.2 Indemnification by Pfizer 20 8.3 Claim for Indemnification 20 ARTICLE 9 TERM; TERMINATION 21 9.1 Term 21 9.2 Early Termination of the Agreement 22 9.3 Effects of Termination 22 ARTICLE 10 CONFIDENTIALITY; NON-USE 23 10.1 Confidential Information 23 10.2 Excluded Information 24 10.3 Terms of the Agreement 24 10.4 Publicity; Use of Names 24 ARTICLE 11 MISCELLANEOUS 24 11.1 Dispute Resolution; Escalation 24 11.2 Arbitration 25 11.3 Governing Law; Jurisdiction and Venue 25 11.4 Assignment and Successors 25 11.5 Force Majeure 26 11.6 Notices 26 11.7 Waiver 27 11.8 Severability 27 11.9 Entire Agreement 27 11.10 Independent Contractors 27 11.11 Interpretation 27 11.12 Further Actions 28 11.13 Construction of Agreement 28 11.14 Counterparts 28 11.15 Compliance with Laws 28 11.16 Performance by Affiliates 28 STRATEGIC COLLABORATION AGREEMENT This STRATEGIC COLLABORATION AGREEMENT (the “Agreement”) is entered into as of November 17, 2020 (the “Effective Date”), by and between LianBio, an exempted company organized under the laws of the Cayman Islands (the “Company”) and Pfizer Inc., a Delaware corporation, having an address of 000 Xxxx 00xx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (“Pfizer”). The Company and Pfizer each may be referred to herein individually as a “Party” or collectively as the “Parties.” All attached appendices and exhibits are a part of this Agreement.
Joint Collaboration Committee. The Parties hereby establish a committee to facilitate the Collaboration as follows:
Joint Collaboration Committee. Promptly following the Effective Date, the Parties will establish a joint collaboration committee (the “Joint Collaboration Committee” or “JCC”) to (i) facilitate information-sharing and coordination with respect to the status and progress of Development, regulatory activities, Manufacturing and Commercialization of Product, (ii) to review and make decisions with respect to matters subject to JCC approval and (iii) provide a forum for discussing and resolving issues with respect to the conduct of the Collaboration. The Parties may designate the JCC as the forum for discussing and agreeing on matters subject to mutual agreement of the Parties hereunder. The JCC shall have no authority to amend, modify or waive compliance with this Agreement, to make decisions that conflict with the terms and conditions of this Agreement, or to create new obligations for a Party not specified in this Agreement. Each Party shall keep the other Party and the JCC informed of the progress and results of its activities under the Development Plan and Commercialization Plan and with respect to regulatory activities and supply of the Product, in each case with respect to its Licensed Territories. The JCC may establish sub-committees to coordinate or manage specific aspects of the Collaboration (e.g., product supply, financial reporting).
